Inovox Orange

Amylmetacresol, 2,4‑Dichlorobenzyl Alcohol and Lidocaine Hydrochloride, the active ingredients in Inovox Orange, are an antiseptic and local anesthetic combination presented as an oromucosal preparation for oral use. It provides relief of sore throat and temporary relief of oral mucosal irritation.

GNH USA supplies Inovox Orange as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inovox Orange, an antiseptic and local anesthetic combination, is used for conditions affecting the oral mucosa. - Sore throat: provides symptomatic relief of pain and irritation. - Mouth ulcers: temporarily reduces pain associated with oral lesions. - Oral mucosal irritation: eases discomfort caused by irritation or inflammation.

Adverse reactions may occur with use of Inovox Orange.

Common Side Effects: - Mild oral tingling. - Transient numbness of the mouth. - Slight alteration in taste. - Mild dryness of the mouth.

Serious or Rare Side Effects: - Allergic reactions such as rash, swelling, or urticaria. - Anaphylaxis. - Severe oral mucosal ulceration. - Persistent numbness beyond the expected duration. - Respiratory difficulty or bronchospasm.

Before using Inovox Orange, consider the following precautions. - Allergy assessment: verify no known hypersensitivity to any component. - Use in children: limit use to age groups recommended by a healthcare professional. - Concomitant oral anesthetics: avoid simultaneous use of other topical anesthetics to prevent excess numbness. - Underlying conditions: exercise caution in patients with severe oral infections or extensive lesions. - Pregnancy and lactation: consult a healthcare provider before use as safety data are limited. - Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Potential drug interactions should be reviewed prior to therapy.

Major Interactions (Avoid): - Concurrent use of other topical anesthetics: may increase risk of systemic toxicity. - MAO inhibitors: may potentiate lidocaine effects, though rare. - Alcohol‑containing oral products: can enhance local irritation.

Moderate Interactions (Monitor Closely): - Systemic analgesics (e.g., opioids): monitor for additive analgesic effect. - Antihistamines: may increase perception of numbness. - CYP3A4 substrates: lidocaine is metabolised by CYP3A4, monitor levels of drugs with narrow therapeutic windows.